HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ceshi Chen Selected Research

Factor V (Coagulation Factor V)

10/2021Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.
11/2019USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5.
1/2019Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers.
12/2018Krüpple-like factor 5 is essential for mammary gland development and tumorigenesis.
1/2018Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1.
2/2017Dexamethasone induces docetaxel and cisplatin resistance partially through up-regulating Krüppel-like factor 5 in triple-negative breast cancer.
8/2015Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5).
9/2013Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer.
1/2013Role of KLF5 in hormonal signaling and breast cancer development.
7/2011The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ceshi Chen Research Topics

Disease

59Neoplasms (Cancer)
01/2022 - 09/2002
53Breast Neoplasms (Breast Cancer)
01/2022 - 09/2002
22Triple Negative Breast Neoplasms
01/2022 - 09/2013
15Carcinogenesis
11/2019 - 04/2003
7Neoplasm Metastasis (Metastasis)
01/2022 - 04/2012
5Prostatic Neoplasms (Prostate Cancer)
01/2013 - 04/2005
4Carcinoma (Carcinomatosis)
10/2021 - 06/2009
4Lung Neoplasms (Lung Cancer)
01/2020 - 07/2015
3Hypoxia (Hypoxemia)
01/2021 - 01/2018
2Liver Neoplasms (Liver Cancer)
01/2021 - 06/2012
2Inflammation (Inflammations)
11/2018 - 01/2014
2Infections
01/2018 - 01/2016
2Pathologic Processes
01/2013 - 03/2006
2Ductal Carcinoma
06/2009 - 06/2006
1Colonic Neoplasms (Colon Cancer)
01/2021
1Cysts
01/2021
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021
1Cachexia
01/2021

Drug/Important Bio-Agent (IBA)

25Transcription Factors (Transcription Factor)IBA
01/2022 - 09/2002
16Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2005
12UbiquitinIBA
01/2021 - 05/2005
10Pharmaceutical PreparationsIBA
01/2022 - 10/2006
10Factor V (Coagulation Factor V)IBA
10/2021 - 07/2011
10Biomarkers (Surrogate Marker)IBA
06/2021 - 12/2007
10Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
04/2020 - 12/2005
9Messenger RNA (mRNA)IBA
01/2022 - 09/2002
6Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA
01/2022 - 04/2003
6Ligases (Synthetase)IBA
01/2021 - 10/2006
6Estrogen ReceptorsIBA
01/2020 - 06/2009
5Small Interfering RNA (siRNA)IBA
01/2022 - 05/2006
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2013
5EnzymesIBA
01/2021 - 09/2019
4Deubiquitinating EnzymesIBA
01/2022 - 08/2015
4Transforming Growth Factor beta (TGF-beta)IBA
02/2016 - 06/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 04/2012
3Phenobarbital (Luminal)FDA Link
01/2021 - 01/2016
3Mifepristone (RU 486)FDA Link
01/2020 - 01/2016
3Proline (L-Proline)FDA Link
01/2020 - 09/2019
3Estrogens (Estrogen)FDA Link
01/2014 - 07/2011
2Histone Deacetylase InhibitorsIBA
01/2022 - 09/2019
2Long Noncoding RNAIBA
01/2022 - 01/2021
2TriterpenesIBA
01/2021 - 01/2016
2EconazoleFDA LinkGeneric
01/2020 - 12/2017
2oridoninIBA
11/2019 - 10/2016
2Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2019 - 02/2017
2Biological ProductsIBA
01/2019 - 12/2007
2GlucocorticoidsIBA
01/2019 - 02/2017
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2019 - 07/2006
2Ursolic AcidIBA
02/2018 - 04/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 12/2007
2Indicators and Reagents (Reagents)IBA
04/2017 - 04/2012
2lissamine rhodamine B (sulforhodamine B)IBA
02/2017 - 01/2013
2AndrogensIBA
02/2016 - 01/2013
2Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
02/2016 - 12/2014
29,10-Dimethyl-1,2-benzanthraceneIBA
02/2016 - 12/2014
2Hormones (Hormone)IBA
01/2016 - 01/2013
2Therapeutic UsesIBA
01/2014 - 07/2006
2ProgesteroneFDA LinkGeneric
01/2013 - 07/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2012 - 12/2007
2Proteasome Endopeptidase Complex (Proteasome)IBA
06/2010 - 05/2005
1Antisense OligonucleotidesIBA
01/2022
1Y-Box-Binding Protein 1IBA
01/2022
1AntigensIBA
01/2022
1Protein Kinases (Protein Kinase)IBA
01/2022
1Keratin-16 (Keratin 16)IBA
01/2022
1polypeptide 3 90kDa ribosomal protein S6 kinaseIBA
01/2022
16-methyladenineIBA
01/2022
1Tumor Biomarkers (Tumor Markers)IBA
01/2022
1Tadalafil (Cialis)FDA Link
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1CXC ChemokinesIBA
01/2022
1Mitogen-Activated Protein KinasesIBA
01/2022
1ChromatinIBA
10/2021
1CytokinesIBA
10/2021
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
10/2021
1human PRMT2 proteinIBA
10/2021
1Lactic Acid (Lactate)FDA LinkGeneric
01/2021
1Cysteine (L-Cysteine)FDA Link
01/2021
1Cystine (L-Cystine)IBA
01/2021
1MTOR InhibitorsIBA
01/2021
1Lapatinib (GW572016)FDA Link
01/2021
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2021
1Fructose-Bisphosphate Aldolase (Aldolase)IBA
01/2021
1pyrimidineIBA
01/2021
1Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA
01/2021
1Ubiquitin-Conjugating EnzymesIBA
01/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021
1EphrinsIBA
01/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021
1Sirolimus (Rapamycin)FDA Link
01/2021
1Amino AcidsFDA Link
01/2021
1PesticidesIBA
01/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021

Therapy/Procedure

21Therapeutics
01/2022 - 01/2013
4Drug Therapy (Chemotherapy)
01/2021 - 02/2017
2Immunotherapy
01/2022 - 10/2021
1Enteral Nutrition (Feeding, Tube)
01/2021
1Parenteral Nutrition
01/2021